Poison exons: tuning RNA splicing for targeted gene regulation.

IF 19.9 1区 医学 Q1 PHARMACOLOGY & PHARMACY Trends in pharmacological sciences Pub Date : 2025-03-01 Epub Date: 2025-02-05 DOI:10.1016/j.tips.2025.01.002
Christopher R Neil, Cassandra Schaening-Burgos, Maria S Alexis, Dominic J Reynolds, Peter G Smith, Michael W Seiler, Frédéric H Vaillancourt, Anant A Agrawal
{"title":"Poison exons: tuning RNA splicing for targeted gene regulation.","authors":"Christopher R Neil, Cassandra Schaening-Burgos, Maria S Alexis, Dominic J Reynolds, Peter G Smith, Michael W Seiler, Frédéric H Vaillancourt, Anant A Agrawal","doi":"10.1016/j.tips.2025.01.002","DOIUrl":null,"url":null,"abstract":"<p><p>Poison exons (PEs) are a class of alternatively spliced exons whose inclusion targets mRNA transcripts for degradation via the nonsense-mediated decay (NMD) pathway. Although a role for NMD as an essential mRNA quality control pathway has long been appreciated, recent advances in RNA sequencing (RNA-seq) strategies and analyses have revealed that its coupling to RNA splicing is broadly used to regulate mRNA stability and abundance. Regulation of PE splicing affects patterns of targeted degradation across the transcriptome and influences gene expression in both healthy and disease states. Importantly, PEs represent a novel therapeutic opportunity to modulate the expression of disease-relevant genes with sequence-specific resolution. We review the emergence of PE splicing in endogenous gene regulation, its misregulation in disease, and the ways in which it can be leveraged for therapeutic benefit.</p>","PeriodicalId":23250,"journal":{"name":"Trends in pharmacological sciences","volume":" ","pages":"264-278"},"PeriodicalIF":19.9000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in pharmacological sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.tips.2025.01.002","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Poison exons (PEs) are a class of alternatively spliced exons whose inclusion targets mRNA transcripts for degradation via the nonsense-mediated decay (NMD) pathway. Although a role for NMD as an essential mRNA quality control pathway has long been appreciated, recent advances in RNA sequencing (RNA-seq) strategies and analyses have revealed that its coupling to RNA splicing is broadly used to regulate mRNA stability and abundance. Regulation of PE splicing affects patterns of targeted degradation across the transcriptome and influences gene expression in both healthy and disease states. Importantly, PEs represent a novel therapeutic opportunity to modulate the expression of disease-relevant genes with sequence-specific resolution. We review the emergence of PE splicing in endogenous gene regulation, its misregulation in disease, and the ways in which it can be leveraged for therapeutic benefit.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
毒性外显子:调整RNA剪接以进行靶向基因调控。
毒性外显子(PEs)是一类选择性剪接的外显子,其内含物通过无义介导的衰变(NMD)途径靶向mRNA转录物降解。虽然NMD作为重要的mRNA质量控制途径的作用早已被认识到,但RNA测序(RNA-seq)策略和分析的最新进展表明,它与RNA剪接的偶联被广泛用于调节mRNA的稳定性和丰度。PE剪接的调节影响转录组中靶向降解的模式,并影响健康和疾病状态下的基因表达。重要的是,pe代表了一种新的治疗机会,可以通过序列特异性分辨率调节疾病相关基因的表达。我们回顾了PE剪接在内源性基因调控中的出现,它在疾病中的错误调控,以及它可以用于治疗益处的方式。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
23.90
自引率
0.70%
发文量
132
审稿时长
6-12 weeks
期刊介绍: Trends in Pharmacological Sciences (TIPS) is a monthly peer-reviewed reviews journal that focuses on a wide range of topics in pharmacology, pharmacy, pharmaceutics, and toxicology. Launched in 1979, TIPS publishes concise articles discussing the latest advancements in pharmacology and therapeutics research. The journal encourages submissions that align with its core themes while also being open to articles on the biopharma regulatory landscape, science policy and regulation, and bioethics. Each issue of TIPS provides a platform for experts to share their insights and perspectives on the most exciting developments in the field. Through rigorous peer review, the journal ensures the quality and reliability of published articles. Authors are invited to contribute articles that contribute to the understanding of pharmacology and its applications in various domains. Whether it's exploring innovative drug therapies or discussing the ethical considerations of pharmaceutical research, TIPS provides a valuable resource for researchers, practitioners, and policymakers in the pharmacological sciences.
期刊最新文献
Complement dysregulation in multiple sclerosis: emerging mechanisms and translational therapeutic opportunities. Formyl peptide receptors as therapeutic targets in eye disease. Targeting metabolism to combat anticancer and antibacterial drug resistance. Zycubo (copper histidinate), the first treatment for pediatric Menkes disease. Cancer pathogenesis and phase targeting through condensate fragility.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1